Hase Aditi Dattatraya, Banerjee Sanjay K
Department of Biotechnology, National Institute of Pharmaceutical Education and Research (NIPER), Guwahati, Assam, India.
Results Probl Cell Differ. 2025;75:247-290. doi: 10.1007/978-3-031-91459-1_9.
This chapter highlights the hallmarks of cardiac aging, distinguishing characteristics between cardiac aging and cardiac senescence. An overview of the molecular mechanisms underlying cardiac aging, with a particular focus on the role of reversible protein acetylation, emphasizes the role of sirtuins in regulating heart function and structure. The chapter explores how alterations in energy metabolism contribute to heart dysfunction, with a focus on the impact of mitochondrial dysfunction and phenomena of protein acetylation, along with the role of acetylase and deacetylase in an aging heart. Additionally, the chapter discusses the regulation of cardiomyocyte proliferation and the potential for enhancing cardiac regeneration. Finally, therapeutic strategies, including caloric restriction and HDAC inhibitors, microRNAs, stem cells, and other pharmacological agents are examined as potential approaches to slow or reverse the effects of cardiac aging.
本章重点介绍心脏衰老的特征、心脏衰老与心脏衰老之间的区别特征。概述心脏衰老背后的分子机制,特别关注可逆性蛋白质乙酰化的作用,强调去乙酰化酶在调节心脏功能和结构中的作用。本章探讨能量代谢改变如何导致心脏功能障碍,重点关注线粒体功能障碍和蛋白质乙酰化现象的影响,以及乙酰化酶和去乙酰化酶在衰老心脏中的作用。此外,本章还讨论了心肌细胞增殖的调节以及增强心脏再生的潜力。最后,研究了包括热量限制和HDAC抑制剂、微小RNA、干细胞及其他药物制剂在内的治疗策略,将其作为减缓或逆转心脏衰老影响的潜在方法。